Zusammenfassung
„Dysthymie“ stammt aus dem Griechischen und bedeutet „Verstimmtsein“ bzw. „schlechte Laune“. Der Begriff Dysthymie findet sich bereits im 19. Jahrhundert in der französischen, englischen und deutschen psychiatrischen Literatur als Synonym für Depression, in die deutschsprachige Psychiatrie wurde er von C.F. Flemming 1844 eingeführt. „Dysthymie“ wurde von ihm als Synonym für „Gemüthsstörungen“ benutzt und darunter wurden verschiedene Affektstörungen subsumiert (Flemming 1844). Kahlbaum verstand als Erster den Dysthymiebegriff ähnlich seiner heutigen Bedeutung: Er wies in seiner Einteilung der psychiatrischen Krankheiten auf den Ausgang als Ordnungskriterium hin und differenzierte deshalb zwischen „Dysthymie“ und „Melancholie“ (Kahlbaum 1878). Die Dysthymie verlaufe zwar chronisch, aber mit guter Prognose, während die Melancholie die Tendenz habe, „schließlich in den Blödsinn überzugehen“. In der deutschsprachigen Psychiatrie des 20. Jahrhunderts ist der Begriff Dysthymie ausgesprochen vieldeutig. Weitbrecht (1949) prägte den Begriff der „endoreaktiven Dysthymie“, die zwischen endogener und reaktiver Depression zu finden ist. Dabei schilderte er die Symptomatik teilweise vergleichbar mit den modernen Dysthymiekonzepten: Lange Verläufe einer eher missmutig anmutenden Verstimmung, häufig mit Hypochondrie verbunden, ohne Manien oder primäre Schuldgefühle bei erschöpfbaren, reizbaren, eher asthenischen Menschen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akiskal HS (1983) Dysthymic disorders: Psychopathology of proposed chronic depressive subtypes. Am J Psychiatry 140:11–20.
Akiskal HS (1990) Towards a definition of dysthymia: boundaries with personality and mood disorders. In: Burton SW, Akiskal HS (eds) Dysthymic disorder. Gaskell, London, pp 1–12.
Akiskal HS (1994 a) Dysthymia: clinical and external validity. Acta Psychiatr Scand 383 [Suppl]: 19–23.
Akiskal HS (1994b) Dysthymic and cyclothymic depressions: therapeutic considerations. J Clin Psychiatry 55 [Suppl 4]:46–52.
Akiskal HS (1996) Dysthymia as a temperamental variant of affective disorder. Eur Psychiatry 11 [Suppl 3]:117–122.
Akiskal HS (1998) Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the „borderline“ realm. Psychiatr Clin North Am 4:25–46.
Akiskal HS, Bitar AH, Puzantian VR et al. (1978) The nosological status of neurotic depression. Arch Gen Psychiatry 35:757–766.
Akiskal HS, Rosenthal TL, Haykal RF et al. (1980) Characterological depressions: „Clinical and sleep EEG findings separating“ „subaffective dysthymias“ from „characterspectrum“ disorders. Arch Gen Psychiatry 37:777–783.
Akiskal HS, King D, Rosenthal TL et al. (1981) Chronic Depressions. Part 1. Clinical and familial characteristics in 137 probands. J Affect Disord 3:297–315.
Akiskal HS, Weise RE (1992) The clinical spectrum of so-called „minor“ depressions. Am J Psychother 46:9–22.
Akiskal HS, Judd LL, Gillin JC et al. (1997) Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms. J Affect Disord 45:53–63.
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders: ed 3 - DSM-III. American Psychiatric Association, Washington DC.
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders: ed 3 - revised version (DSM-III-R). American Psychiatric Association, Washington DC.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: ed 4 - DSM-IV. American Psychiatric Association, Washington DC.
Angst J. (1994) The history and concept of recurrent brief depression. Eur Arch Psychiatry Clin Neurosci 244:171–173.
Angst J (1995) The epidemiology of depressive disorders. Eur Neuropsychopharmacol 5 [Suppl]:95–98.
Angst J, Dobler-Mikola A (1985) The Zurich study — a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression. Eur Arch Psychiatr Neurol Sci 234:408–416.
Angst J, Merikangas KR, Scheidegger P et al. (1990) Recurrent brief depressions: a new sub-type of affective disorder. J Affect Disord 19:37–38.
Angst J, Wicki W (1991) The Zurich study. XI. Is dysthymia a separate form of depression? Results of the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci 240:349–354.
Angst J, Merikangas KR (1997) The depressive spectrum: diagnostic classification and course. J Affect Disord 45:31–39.
Arriaga F, Rosado P, Paiva T (1990) The sleep of dysthymic patients: a comparison with normal controls. Biol Psychiatry 27:649–656.
Rakish D, Lapierre YD, Weinstein R et al. (1993) Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J Chn Psychopharmacol 13:409–414.
Bakish D, Ravindran A, Hooper C et al. (1994) Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacol Bull 30:53–59.
Bersani G, Pozzi F, Marini S et al. (1991) 5HT2 receptor antagonism in dysthymic disorder: a double-blind placebo control with ritanserin. Acta Psychiatrica Scand 83:244–248.
Binswanger O (1915) Allgemeine Psychiatrie. In: Binswanger O, Siemerling E (Hrsg) Lehrbuch der Psychiatrie, 4. Aufl. Gustav Fischer, Jena.
Blazer DG (1994) Dysthymia in community and clinical samples of older adults. Am J Psychiatry 151:1567–1569.
Bloch AL, Shear MK, Markowitz et al. (1993) An empirical study of defense mechanisms in dysthymia. Am J Psychiatry 150:1194–1198.
Botte L, Gilles G, Evrard JL et al. (1990) Moclobemide versus placebo in the treatment of depression: a multi centre study in Belgium. Acta Psychiatr Scand 82:42.
Boyer P, Lecrubier Y, Stalla-Bourdillon A et al. (1999) Amisulpride versus amineptine and placebo for the treatment of dysthymia. Neuropsychobiology 39:25–32.
Brambilla F, Musetti C, Tacchini C et al. (1989) Neuroendocrine investigations in children and adolescents with dysthymic disorders: The DST, TRH and clonidine test. J Affect Disord 17:279–284.
Brieger P, Marneros A (1995) Das Dysthymiekonzept: Aktuelles and Geschichtliches - Ein Gberblick. Fortschr Neurol Psychiat 63:410–420.
Bronisch T (1990) Dysthyme St6rungen. Nervenarzt 61:133–139.
Brunello N, Akiskal H, Boyer P et al. (1999) Dysthymia: Clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. J Affect Disord 52:275–290.
Bumke O (1948) Lehrbuch der Geisteskrankheiten, 7. Aufl. JF Bergmann, Munchen; Sprin-ger, Berlin Göttingen Heidelberg.
Burton SW, Akiskal HS (1990) Dysthymic disorder. Gaskell, London.
Costa-e-Silva JA (1990) Treatment of dysthymic disorder with low-dose amisulpride. A comparative study of 50 mg/day amisulpride versus placebo. Ann Psychiatry 5:242–249.
De Jong R, Treiber R, Heurich G (1986) Effectiveness of two psychological treatmens for in-patients with severe and chronic depression. Cognitive Ther Res 10:645–663.
De Jong-Meyer (2000) Verhaltenstherapie dysthymer Patienten. In: Moller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, New York, S 792–804.
Devanand DP, Nobler MS, Singer T et al. (1994) Is dysthymia a different disorder in the elderly? Am J Psychiatry 151:1592–1599.
Dilling H, Mombour W, Schmidt H (1991) Internationale Klassifikation psychischer Störungen. ICD-10, Kap. V (F). Khnisch-diagnostische Leitfinien. Hans Huber, Bern.
Donaldson SK, Klein DN, Riso LP et al. (1997) Comorbidity between dysthymic and major depressive disorders: a family study analysis. J Affect Disord 42:103–111.
Dunner DL, Hendrickson HE, Bea C et al. (1997) Venlafaxine in dysthymic disorder. J Chn Psychiatry 58:528–531.
Dunner DL, Schmaling KB, Hendrickson H et al. (1996) Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 4:34–41.
Eames SL, Westermeyer J, Crosby RD (1998) Substance use and abuse among patients with comorbid dysthymia and substance disorder. Am J Drug Alcohol Abuse 24:541–550.
Flemming CF (1844) Ueber Classification der Seelenst6rungen nebst einem Versuch derselben, mit besonderer Riicksicht auf gerichtfiche Psychologie. Allgemeine Zeitschrift fur Psychiatrie and psychisch-gerichtliche Medizin 1:97–130.
Freeman HL (1994) Historical and nosological aspects of dysthymia. Acta Psychiatr Scand 89 [Suppl 383]:7–11.
Friedman RA, Mitchell J, Kocsis JH (1995a) Retreatment for relapse following desipramine discontinuation in dysthymia. Am J Psychiatry 152:926–928.
Friedman RA, Parides M, Baff R et al. (1995b) Predictors of response to desipramine in dysthymia. J Clin Psychopharm 15:280–283.
Garyfallos G, Adamopoulou A, Karastergiou A et al. (1999) Personality disorders in dysthymia and major depression. Acta Psychiat Scand 99:332–340.
Goldstein RB, Weissman MM, Adams PB et al. (1994) Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch Gen Psychiatry 51:383–394.
Goodman DW, Barnhill J (1995) Family and genetic epiderniologic studies. In: Kocsis JH, Klein DN (eds) Diagnosis and treatment of chronic depression. Guilford Press, New York, pp 103–123.
Griffith J, Ravindran AV, Merali Z, Anisman H (2000) Dysthymia: a review of pharmacological and behavioral factors. Molecular Psychiatry 5:242–261.
Harpin RE, Liberman RP, Marks I et al. (1982) Cognitive-behavior therapy for chronically depressed patients: a controlled pilot study. J New Ment Dis 170:295–301.
Harrison W, Rabkin J, Stewart JW et al. (1986) Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry 47:346–349.
Haykal R, Akiskal HS (1999) The long-term outcome of dysthymia in private practice: Clinical features, temperament, and the art of management. J Clin Psychiatry 60:508–518.
Hellerstein DJ, Yanowitch JP, Rosenthal J et al. (1993) A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 150:1169–1175.
Hellerstein DJ, Yanowitch JP, Rosenthal J et al. (1994) Long-term treatment of double depression: a preliminary study with serotonergic antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 18:139–147.
Hellerstein DJ, Wallner Samstag L, Cantillon M et al. (1996) Follow-up assessment of medication-treated dysthymia. Prog Neuropsychopharmacol Biol Psychiatry 20:427–442.
Hirschfeld RMA (1990) Personality and dysthymia. In: Burton SW, Akiskal HS (eds) Dysthymic Disorders. Gaskell, London, pp 69–77.
Hirschfeld RMA (1994) Major depression, dysthymia and depressive personality disorder. Br J Psychiatry 165 [Suppl 26]:23–30.
Hirschfeld RMA, Klerman GL, Andreasen NC et al. (1986) Psycho-social predictors of chronicity in depressed patients. Br J Psychiatry 148:648–654.
Horwath E, Johnson J, Klerman GL et al. (1992) Depressive symptoms as relative and attributable risk factors for first-onset-major depression. Arch Gen Psychiatry 49:817–823.
Howland RH (1991) Pharmacotherapy of dysthymia: a review. J Clin Psychopharmacology 11:83–92.
Howland RH, Thase ME (1991) Biological studies of dysthymia. Biol Psychiatry 30:283–304.
Huber G, Glatzel J, Lungershausen E (1969) Ober zyklothyme Residualsyndrome. In: Schulte W, Mende W (Hrsg) Melancholie in Forschung, Klinik and Behandlung. Thieme, Stuttgart, S 42–46.
Judd LL, Rapaport MH, Paulus MB et al. (1994) Subsyndromal. Symptomatic Depression: a new mood disorder? J Clin Psychiatry 55:18–28.
Judd LL, Paulus MB, Wells KB, et al. (1996) Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 153:1411–1417.
Judd LL, Akiskal HS, Paulus MP (1997) The role and clinical significance of subsyndromal depressive syndromes (SSD) in unipolar major depressive disorder. J Affect Disord 45:5–17.
Judd LL, Akiskal HS, Maser JD et al. (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694–700.
Kahlbaum K (1878) Die klinisch-diagnostischen Gesichtspunkte der Psychopathologie. Breitkopf u. Hartel, Leipzig, Sammlung klinischer Vortrdge 126:1127–1146.
Katona CLE, Bell GT (1990) Depression and dysphoria in old age. In: Burton SW, Akiskal HS (eds) Dysthymic disorder. Gaskell, London, pp 49–68.
Keller F (1994) Belastende Lebensereignisse und der Verlauf von Depressionen. Internationale Hochschulschriften, Bd 241, Munster, New York.
Keller MB, Shapiro PW (1982) „Double-depression“: Superimpositions of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 139:438–442.
Keller MB, Lavori PW, Endicott J et al. (1983) „Double Depression“: two-year follow up. Am J Psychiatry 140:689–694.
Keller MB, Sessa FM (1990) Dysthymia: development and clinical course. In: Burton SW, Akiskal HS (eds). Dysthymic Disorders. Gaskell, London, pp 13–23.
Keller MB, Klein DN, Hirschfeld RM et al. (1995) Results of the DSM-IV mood disorders field trial. Am J Psychiatry 152(6):843–849.
Keller MB, Gelengerg AJ, Hirschfeld RN et al. (1998) The treatment of chronic depression, part 2: a double blind, randomized trial of sertraline and imipramine. J Clin Psychiatry 59:598–607.
Kendler KS, Gardner Jr. CO (1998) Boundaries of major depression: evaluation of DSM-IV criteria. Am J Psychiatry 155:172–177.
Kessler RC, McGonagle KA, Zhao S et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8–19.
Klein DN, Taylor EB, Harding K et al. (1988a) Double depression and episodic major depression: demographic, clinical, familial, personality and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 145:1226–1231.
Klein DN, Taylor EB, Dickstein S et al. (1988b) Primary early-onset dysthymia: comparison with primary nonbipolar nonchronic major depression on demographic, clinical, familial, personality and socioenvironmental characteristics and short-term outcome. J Abnorm Psychol 97:387–398.
Klein DN, Riso LP, Donaldson et al. (1995) Family study of early-onset dysthymia. Arch Gen Psychiatry 52:487–496.
Klein DN, Kocsis JH, McCullough IP et al. (1996) Symptomatology in dysthymic and major depressive disorder. Psychiat Clin North Am 19:41–53.
Klein DN, Taylor EB, Dickstein S et al. (1998) The early-late onset distinction in DSM-III-R dysthymia. J Affect Disord 14:25–33.
Klein DN, Schatzberg AF, McCullough JP et al. (1999) Early - versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes. J Affect Disord 52:187–196.
Kocsis JH, Frances A, Mann JJ et al. (1985) Imipramine for treatment of chronic depression. Psychopharmacol Bull 21:698–700.
Kocsis JH, Frances AJ (1987) A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 144:1534–1542.
Kocsis JH, Frances AJ, Voss C et al. (1988a) Imipramine treatment for chronic depression. Arch Gen Psychiatry 45:253–257.
Kocsis JH, Frances AJ, Voss C et al. (1988b) Imipramine and social vocational adjustment in chronic depression. Am J Psychiatry 145:997–999.
Kocsis JH, Mason BJ, Frances A et al. (1989) Prediction of response of chronic depression to imipramine. J Affective Disord 17:255–260.
Kocsis JH, Those M, Koran L et al. (1994) Pharmacotherapy of pure dysthymia: sertraline vs imipramine and placebo. Eur Neuropsychopharm 4 [Suppl 3]:S204.
Kocsis JH, Friedman RA, Markowitz JC et al. (1995) Stability of remission during tricyclic antidepressant continuation therapy for dysthymia. Psychopharmacol Bull 31:213–216.
Kocsis JH, Friedman RA, Markowitz JC et al. (1996) Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. Arch Gen Psychiatry 53:769–774.
Kocsis JH, Zisook S, Davidson J et al. (1997) Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 145:390–395.
Kovacs M, Feinberg TL, Crouse-Novak MA et al. (1984) Depressive disorder in childhood. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 41:229–237.
Kovacs M, Akiskal HS, Gatsonis C et al. (1994) Childhood onset of dysthymic disorder: clinical features and prospective naturalistic outcome. Arch Gen Psychiatry 51:365–374.
Lapierre YD (1994) Pharmacological therapy of dysthymia. Acta Psychiatr Scand 89 [Suppl 383]:42–48.
Leonhard K (1968) Akzentuierte Persönlichkeiten. VEB Verlag Volk and Gesundheit, Berlin.
Levitt AJ, Joffe RT, Sopkolov STH (1998) Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants? J Affect Disord 42:145–153.
Lewinsohn PM, Rohde P, Seeley JR et al. (1991) Comorbidity of unipolar depression: 1. Major depression with dysthymia. J Abnorm Psychol 100:205–213.
Lopez Ibor JJ, Frances A, Jones C (1994) Dysthymic disorder: a comparison of DSM-1V and ICD-10 and issues in differential diagnosis. Acta Psychiatr Scand 89 [Suppl 383]:12–18.
Lynskey MT (1998) The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug Alcohol Depend 52:201–209.
Maier W, Lichtermann D, Minges J et al. (1992) The risk of minor depression in family of probands with major depression: sex differences and familiality. Eur Arch Psychiatry Chn Neurosci 242:89–92.
Marin DB, Kocsis JH, Frances AJ et al. (1994) Desipramine for the treatment of „pure“ dysthymia versus „double“ depression. Am J Psychiatry 151:1079–1080.
Markowitz JC (1994) Psychotherapy of dysthymia. Am J Psychiatry 151:1114–1121.
Markowitz JC, Moron ME, Kocsis JH et al. (1992) Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord 24:63–71.
Markowitz JC, Friedman RA, Miller N et al. (1996) Interpersonal improvement in chronically depressed patients treated with desipramine. J Affect Disord 41:59–62.
Mathew RJ, Wilson WH, Blazer DG et al. (1993) Psychiatric disorders in adult children of alcoholics: data from the Epidemiologic Catchment Area project. Am J Psychiatry 150:793–800.
Maurer J, Volz HP (2000) Psychopharmakotherapie der Dysthymie. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, New York, S 786–792.
McCullough JP (1991) Psychotherapy for dysthymia. A naturalistic study of ten patients. J New Ment Dis 179:734–740.
McCullough JP, Kasnetz MD, Braith JA et al. (1988) A longitudinal study of an untreated sample of predominantly late onset characterological dysthymia. J New Ment Dis 176:658–667.
McCullough JP, Braith JA, Chapman RC et al. (1990) Comparison of early and late onset dysthymia. J New Ment Dis 178:577–581.
McCullough JP, McCune KJ, Kaye AL et al. (1994a) One-Year prospective replication study of an untreated sample of community dysthymia subjects. J New Ment Dis 182:396–401.
McCullough JP, McCune KJ, Kaye AL et al. (1994b) Comparison of a community dysthymia sample at screening with a matched group of non-depressed community controls. J New Meet Dis 182:402–407.
McCullough JP, Kornstein SG, McCullough JP et al. (1996) Differential diagnosis of chronic depressive disorders. Psychiatr Clin North Am 19:41–53.
Miller IW, Norman WH, Dow MG (1986) Psychosocial characteristics of „double depression“. Am J Psychiatry 143:1042–1044.
Millon T, Kotik D (1985) The relationship of depression to disorders of personality. In: Beckham EE, Leher WR (eds) Handbook of depression: treatment, assessment and research. Dorsey Press, Homewood, IL.
Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:335–342.
Nobler MS, Devanand DP, Kimm MK et al. (1996) Fluoxetine treatment of dysthymia in the elderly. J Clin Psychiatry 57:254–256.
Paykel ES, Rowan PR, Parker RR et al. (1982) Response to phenelzine and amitriptyline in some types of depressed outpatients. Arch Gen Psychiatry 39:1041–1049.
Pepper CM, Klein DN, Anderson RL et al. (1995) DSM-III-R axis 11 comorbidity in dysthymia and major depression. Am J Psychiatry 152:239–247.
Pezawas L, Stamenkovic M, Kasper S (2001) Rezidivierende kurze depressive Episoden. Nervenarzt 72:169–180.
Ravindran AV, Bialik RJ, Lapierre YD (1994a) Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry 39:21–26.
Ravindran AV, Bialik RJ, Lapierre YD (1994b) Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test. J Affect Disord 31:111–117.
Ravindran AV, Bialik RJ, Brown GM et al. (1994c) Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolities of serotonin, norepinephrine, epinephrine and melatonin. J Affect Disord 31:119–123.
Ravindran AV, Charbonneau Y, Zaharia M et al. (1998) Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia. J Psychiat Neurosci 23:288–292.
Regier DA, Boyd JH, Burke JD et al. (1988) Onemonth prevalence of mental disorders in the United States. Based on five epidemiological catchment area sites. Arch Gen Psychiatry 45:977–986.
Regier DA, Burke JD, Burke KC (1990) Comorbidity of affective and anxiety disorders in the NIMH Epidemiological Catchnient Area Program. In: Maser JD, Cloninger CR (eds) Co-morbidity of mood and anxiety disorders. American Psychiatric Press, Washington DC, London, pp 113–122.
Regier DA, Narrow WE, Rae DS et al. (1993) Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 50:85–94.
Rihmer Z, Szadockzy E (1993) Dexamethasone suppression test and TRH-TSH test in sub-affective dysthymia and character-spectrum disorder. J Affect Disord 28:287–291.
Robins LN, Helzer JE, Weissman MM et al. (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41:949–958.
Rosenthal TL, Akiskal HS, Scott-Strauss A et al. (1981) Familial developmental factors in characterological depression. J Affect Disord 3:183–192.
Rosenthal J, Hemlock C, Hellerstein DJ et al. (1992) A preliminary study of serotonergic antidepressants in treatment of dysthymia. Prog Neuropsychopharmacol Biol Psychiatry 16:933–941.
Rosenthal J, Hemlock C, Hellerstein DJ et al. (1992) A preliminary study of serotonergic antidepressants in treatment of dysthymia. Prog Neuropsychopharmacol Biol Psychiatry 18:933–941.
Rowan PR, Paykel ES, Parker RR (1982) Phenelzine and amitriptyline: effects on symptoms of neurotic depression. Br J Psychiatry 140:475–483.
Roy A, Sutton M, Picker D (1985) Neuroendocrine and personality variables in dysthymic disorder. Am J Psychiatry 142:94–97.
Rush AJ, Those ME (1997) Strategies and tactics in the treatment of chronic depression. J Clin Psychiatry 58 [Suppl 13]:14–22.
Sanderson WC, Beck AT, Beck J (1990) Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry 147:1025–1028.
Sanderson WC, Wetzler S, Beck AT et al. (1992) Prevalence of personality disorders in patients with major depression and dysthymia. Psychiatry Res 42:93–99.
Santagostino G, Gucchi ML, Frattini P et al. (1998) The influence of alprazolam on the monoaminergic neurotransmitter systems in dysthymic patients. Relationship to clinical response. Pharmacopsychiatry 31:131–136.
Schmauß M, Messer Th (in Vorber.) Komorbiditdtsmuster bei hospitalisierten dysthymen Patienten.
Scott JW, Barker A, Eccleston D (1988) The Newcastle Chronic Depression Study. Patient characteristics and factors associated with chronicity. Br J Psychiatry 152:28–33.
Shelton RC, Davidson J, Yonkers KA et al. (1997) The undertreatment of dysthymia. J Chn Psychiatry 58:59–65.
Sherbourne CD, Wells KB, Hays RD et al. (1994) Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health speciality out-patients. Am J Psychiatry 1512:1777–1784.
Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission. A double-blind, comparative study. J Affect Disord 48:47–56.
Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criterias. Rationale and reliability. Arch Gen Psychiatry 35:773–782.
Stewart JW, McGrath PJ, Liebowitz MR et al. (1983) Efficacy of desipramine in depressed outpatients: response according to research diagnostic criteria diagnoses and severity of illness. Arch Gen Psychiatry 40:202–207.
Stewart JW, McGrath PJ, Liebowitz MR et al. (1985) Treatment outcome validation of DSMIII depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression. Arch Gen Psychiatry 42:1148–1153.
Stewart JW, Quitkin FM, McGrath PJ et al. (1988) Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Res 25:213–222.
Stewart JW, McGrath PJ, Quitkin FM et al. (1989) Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression, Differential response to phenelzine, imipramine, and placebo. Arch Gen Psychiatry 46:1080–1087.
Stewart JW, McGrath PJ, Quitkin FM et al. (1993) Chronic depression: response to placebo, imipramine, and phenelzine. J Clin Psychopharmacology 13: 391–396.
Szadoczky E, Sazekas I, Rihmer Z et al. (1994) The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late onset dysthymia. J Affect Disord 32:1–11.
Thase ME, Fava M, Halbreich U et al. (1996) A placebo-controlled, randomised clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777–784.
Tyrer P, Murphy S, Kingdon D et al. (1988) The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 2:235–240.
Vallejo J, Castro G, Catalan R et al. (1987) Double-blind study of imipramine vs. phenelzine in melancholic and dysthymic disorders. Br J Psychiatry 151:639–642.
Vanelle JM, Atztar-Levy D, Poirier MF et al. (1997) Controlled efficacy study of fluoxetine in dysthymia. Br J Psychiatry 170:345–350.
Versiani M (1993) Pharmacotherapy of dysthymia: a controlled study with imipramine, moclobemide or placebo. Neuropsychopharmacology 10(3S):298.
Versiani M, Nardi E, Capponi R et al. (1992) Moclobemide compared with imipramine in the treatment of chronic depression (dysthymia DSM-III-R). Clin Neuropharmacol 15:148 B.
Versiani M, Amrein R, Stabl M (1997) The International Collaborative Study Group. Moclobemide and imipramine in chronic depression (dysthymia): an international doubleblind, placebo controlled trial. Int Clin Psychopharm 12:183–193.
Weiller E, Boyer P, Lepine JP et al. (1994) Prevalence of recurrent brief depression in primary care. Eur Arch Psychiatry Clin Neurosci 244:174–181.
Weissman MM, Klerman GL (1977) The chronic depressive in the community: Unrecognized and poorly treated. Compr Psychiatry 18:523–532.
Weissman MM, Leaf PJ, Bruce ML et al. (1988) The epidemiology of dysthymia in five communitites: Rates, risks, comorbidity, and treatment. Am J Psychiatry 145:815–819.
Weitbrecht HJ (1949) Zyklothymie. Fortschr Neurol Psychiat 17:437–481.
Wells KB, Burnam MA, Rogers W et al. (1992) The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788–794.
Winokur G, Morrison J (1973) The Iowa 500: Follow-up of 225 depressives. Br J Psychiatry 123:543–548.
Wittchen HU, van Zerssen D (1988) Verldufe behandelter and unbehandelter Depressionen and Angstst6rungen. Eine klinisch-psychiatrische and epidemiologische Verlaufsuntersuchunj. Springer, Berlin, Heidelberg New York Tokyo.
Wittchen HU, Essau CA, von Zerssen D et al. (1992) Lifetime and six-month prevalence of mental disorders in the Munich Follow-up Study. Eur Arch Psychiatry Clin Neurosci 241:247–258.
Wittchen HU, Knauper B, Kessler RC (1994) Lifetime risk of depresion. Br J Psychiatry 26 [Suppl]:16–22.
World Health Organization (1991) Tenth Revision of the International Classification of Disease (ICD-10). World Health Organization, Division of Mental Health, Geneva.
Zisook S, Shuchter SR, Sledge PA et al. (1984) The spectrum of depressive phenomena after spousal bereavement. J Clin Psychiatry 55 [Suppl]:29–36.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schmauss, M., Messer, T. (2002). Dysthymie. In: Laux, G. (eds) Depression 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59394-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-59394-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63963-0
Online ISBN: 978-3-642-59394-9
eBook Packages: Springer Book Archive